TABLE 2. Distribution of the number of metastasis sites, according to the type of KRAS mutation.
Number of metastatic sites | ||||||
---|---|---|---|---|---|---|
Mutation type | Only one | More than one | Total | |||
n | % | n | % | n | % | |
p.G12A | 3 | 12.5% | - | - | 3 | 10.0% |
p.G12C | 1 | 4.2% | - | - | 1 | 3.3% |
p.G12D | 7 | 29.2% | - | - | 7 | 23.3% |
p.G12V | 8 | 33.3% | 2 | 33.3% | 10 | 33.3% |
p.G13C | - | - | 1 | 16.7% | 1 | 3.3% |
p.G13D | 4 | 16.7% | 3 | 50.0% | 7 | 23.3% |
p.G12W | 1 | 4.2% | - | - | 1 | 3.3% |
Total | 24 | 100% | 6 | 100% | 30 | 100% |
n=mutation number